AN OPEN TRIAL COMBINING ZIDOVUDINE, INTERFERON-ALFA, AND RECOMBINANT CD4-IGG WITH TRANSPLANTATION OF SYNGENEIC BONE MARROW AND PERIPHERAL BLOOD LYMPHOCYTES FROM HEALTHY GP160-IMMUNIZED DONORS IN THE TREATMENT OF PATIENTS WITH HIV INFECTION: